Neuro

First Ischemic Stroke Patients Treated With EMBOTRAP II Revascularization Device Since Commercial Availability In U.S.

SAN FRANCISCO, July 24, 2018 /PRNewswire/ — CERENOVUS, part of the Johnson & Johnson Medical Devices Companies, announced the first patients have been treated with its new EMBOTRAP II Revascularization Device since it became commercially available in the U.S. EMBOTRAP II is a next generation stent retriever used to capture and remove life-threatening blood clots […]

Metactive Presents Results from Nonclinical Research Study Treating Carotid Artery Aneurysms

FAIRWAY, Kan.–(BUSINESS WIRE)–Metactive Medical Inc. (Metactive), a medical device company developing innovative products for the treatment of neurovascular and peripheral vascular diseases, announced today that Dr. Kieran Murphy, Professor, Vice Chair, and Director of Research in the Department of Medical Imaging at the University of Toronto, presented new nonclinical results from […]

Perflow Medical Announces the First Clinical Use of the Cascade™ Dynamic Non-Occlusive Remodeling Net

TEL AVIV, Israel, July 23, 2018 /PRNewswire/ — Perflow Medical, an Israeli-based medical device company that develops innovative tools for neurovascular interventions, announces the first clinical cases of the Cascade Dynamic Non-Occlusive Remodeling Net earlier this month by Dr. Alejandro Tomasselo at Hospital Vall d’Hebron in Barcelona, Spain. The Cascade Net is the latest addition […]

Corindus Names Aquilla S. Turk, D.O. as Chief Medical Officer, Neuroendovascular

WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. (NYSE American:CVRS), a leading developer of precision vascular robotics, announced today that Aquilla “Quill” Turk, D.O. has joined the company as Chief Medical Officer, Neuroendovascular. Dr. Turk is a practicing physician at the Medical University of South Carolina where he serves as Director of […]

MIVI Neuroscience Announces First-In-Man Series of The DAISe Clot Management System

EDEN PRAIRIE, Minn., June 29, 2018 /PRNewswire/ — MIVI Neuroscience, Inc. announced today it has successfully achieved first-in-man usage of the DAISe Clot Management System for next generation treatment of ischemic stroke. The proprietary DAISe Clot Management System is uniquely designed to remove clot as well as filter / capture clot emboli that […]

InspireMD’s CGuard EPS Featured at the SBHCI Congress in Brazil

Tel Aviv, Israel, June 20, 2018 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE AMER:NSPR), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced that CGuard™ EPS was featured at the SBHCI Congress, sponsored by the Brazilian Society of Hemodynamics and Interventional Cardiology, which took […]

InspireMD’s CGuard EPS Prominently Featured at the 10th International Congress of the Polish Society for Vascular Surgery

Tel Aviv, Israel, June 18, 2018 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE AMER: NSPR), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced that study results on its CGuard™ EPS were presented at the 10th International Congress of the Polish Society for Vascular Surgery […]

MicroVention Announces FDA Clearance For Thrombectomy Device

ALISO VIEJO, Calif., June 12, 2018 /PRNewswire/ — MicroVention, Inc. a U.S.-based subsidiary of Terumo and a global neurovascular company, announced today the FDA clearance of a new clinical indication for the SOFIA® Catheter (Soft TOrqueable catheter For Intracranial Access) to include contact aspiration technique for successful revascularization among patients with acute ischemic stroke, secondary to intracranial large […]

InspireMD Reports on Expanded 2 Year Follow-up Results from the PARADIGM Clinical Study Using CGuard EPS

TEL AVIV, ISRAEL, May 30, 2018 (GLOBE NEWSWIRE) —  InspireMD, Inc. (NYSE AMER:NSPR), a leader in embolic prevention systems (EPS),  thrombus management technologies and neurovascular devices, today announced that Professor Piotr Musiałek, from the Department of Cardiac and Vascular Diseases, John Paul II Hospital, Kraków, Poland, presented the expanded 24 month […]